Mayo Clinic researchers have discovered a key reason some cancer patients relapse after receiving chimeric antigen receptor T ...

A research team led by Professor Takuya Yamamoto (Department of Life Science Frontiers) and Professor Yasuhiro Yamada at the University of Tokyo has developed a novel in vivo system that reveals how ...

Cancer therapies called checkpoint inhibitor drugs, which ratchet up the immune system, work better when this bacterium is ...

As the founder of Quiet Calm, LLC, a company dedicated to developing sensory solutions for individuals with invisible ...